IFNG and neoplasm: However, when anti-IFNγ antibody was administered simultaneously with cisplatin, it impaired the beneficial effects of chemotherapy (Figure 5A), which was consistent with the observation that IFNγ might be involved in anti-tumour immunity during chemotherapy.